OGT, A Sysmex Group Company, will showcase its soon to be launched SureSeq™ Myeloid MRD Panel at booth #1423 at the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo, 14-18th November in Salt Lake City. The Next-generation sequencing (NGS) panel represents a substantial improvement on conventional flow cytometry and qPCR methods of detecting measurable residual disease (MRD) in acute myeloid leukemia (AML) samples—providing outstanding sensitivity and covera

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical Stimulation ("NMES") device. The M-Wave is set to replace its predecessor, the E-Wave, which has been fundamental in

DeepSight™ Technology, a pioneering force in medical innovation, is thrilled to announce its groundbreaking NeedleVue™ solution. This state-of-the-art ultrasound-guided needle technology ushers in a new era of precision and safety in the field of directed interventional tool guidance, a domain grappling with complexities for several decades. DeepSight's proprietary NeedleVue solution marries innovative sensor technology with most interventional devices, facilitating

The Asia Health Innovation Summit 2023, hosted by global venture accelerator Brinc as part of the StartmeupHK Festival curated by InvestHK, attracted an online audience of over 1,000 and a full capacity of more than 200 in-person attendees at The Park Lane Hong Kong-A Pullman Hotel yesterday. The third-annual event solidified its position as a premier gathering for industry leaders, entrepreneurs, investors, and professionals in Asia's health innovation space. Aimed to foster greater idea

Millar, an OEM solutions provider and leader in pressure sensor medical devices for more than 54 years, announces its strategic intention to acquire Sentron , a renowned and fully integrated manufacturing company for pressure and pH sensors, headquartered in Leek, Netherlands and currently owned by Wellinq. This planned acquisition would mark a significant milestone in the evolution of both companies and foster unparalleled opportunities for innovation and global expansion.&nbs

RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, today announced it has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma. Together with Rapid ICH and Rapid Hyperdensity, the three modules comprise RapidAI’s unique and industry-best hemo

UK based diagnostics technology company Testcard will unveil their cutting-edge non-invasive diagnostic solutions at MEDICA 2023 designed to make testing more accessible for consumers and in clinical settings. As a participant in the ABHI UK Pavilion, Testcard will highlight its innovative technology that transforms a mobile device into a clinical-grade scanner, revolutionising the field of diagnostics.  At MEDICA 2023, the company will showcase its three primary area

Xenter, Inc. ( Xenter.io announced the recent presentation of its revolutionary dual sensor investigational guidewire for TAVR procedures at the Transcatheter Cardiovascular Therapeutics (TCT) conference 2023 in San Francisco, California. real-time to serve as an aortic regurgitation measurement tool (Xar™) and clinical decision support, thereby significantly improving the prediction of paravalvular leak (PVL) during TAVR. The guidewire functionality is designed to enable comp

VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the Center for Medicare & Medicaid Services (CMS) has granted The FLEX Vessel Prep™ System a transitional pass-through (TPT) payment category and a new HCPCS C-code effective January 1, 2024 and will remain in effect for the fo

Baylor College of Medicine, a renowned health sciences institution in Houston, Texas, has teamed up with Luna, the leading provider of in-home outpatient physical therapy, to expand access to patient services. Residents across Houston will have access to convenient, high-quality outpatient physical therapy in the safety and convenience of their own home. Appointments will be available this fall. "Patient access is a big concern for us, given our li